P-082. Endometriosis and in-vitro fertilization: a metaanalysis

In: Human Reproduction · 1999 · vol. 14(Suppl_3) , pp. 181 · doi:10.1093/humrep/14.suppl_3.181-a · W2588083791
article OA: bronze CC0 ⤵ 5 in-corpus citations
📄 Open PDF View on OpenAlex View at publisher
AI-generated summary by claude@2026-06, 2026-06-07

This meta-analysis assessed the impact of endometriosis on uterine blood flow in women undergoing in-vitro fertilization and hormonal replacement therapy.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

and the remammg 53 were non-cycling women. Cycling recipients underwent pituitary down-regulation using GnRH analogue from the midluteal phase of the previous cycle. All patients received hormonal replacement therapy (HRT) with increasing oral doses of micronized 17p-oestradiol starting on day 2 of the cycle. The luteal phase was supported with oily progesterone (100 mg/day/i.m.) and vaginal micronized progesterone (400 mg/day). Recipients' uterine BFV [expressed as pulsatility index (PI)] was assessed by transvaginal colour Doppler ultrasound on day 2 of an HRT previous cycle and on the day of progesterone commencement. Data was analysed using Student's t-test and Fisher's exact test.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

Cited by (5)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK